May 30 (Reuters) - Kalytera Therapeutics Inc KALY.V :
* KALYTERA REPORTS FIRST QUARTER 2018 FINANCIAL RESULTS
* KALYTERA THERAPEUTICS INC - QTRLY LOSS PER SHARE $0.01
* KALYTERA-RECORDED A NET LOSS OF ABOUT $1.9 MILLION ($0.01 PER COMMON SHARE) IN Q1 COMPARED WITH A NET LOSS OF ABOUT $1.6 MILLION ($0.02 PER COMMON SHARE) LAST YEAR
* KALYTERA THERAPEUTICS-AS OF MARCH 31, 2018, HAD CASH AND CASH EQUIVALENTS OF ABOUT $1.9 MILLION, SUFFICIENT TO FUND OPERATING COSTS THROUGH YEAR-END 2018